A CYSTEINE FOR GLYCINE SUBSTITUTION AT POSITION-175 IN AN ALPHA-1-(I)CHAIN OF TYPE-I COLLAGEN PRODUCES A CLINICALLY HETEROGENEOUS FORM OF OSTEOGENESIS-IMPERFECTA
Mk. Wirtz et al., A CYSTEINE FOR GLYCINE SUBSTITUTION AT POSITION-175 IN AN ALPHA-1-(I)CHAIN OF TYPE-I COLLAGEN PRODUCES A CLINICALLY HETEROGENEOUS FORM OF OSTEOGENESIS-IMPERFECTA, Connective tissue research, 29(1), 1993, pp. 1-11
The molecular basis for Osteogenesis Imperfecta in a large kindred wit
h a highly variable phenotype was identified by sequencing the mutant
pro alpha 1 (I) protein, cDNA and genomic DNA from the proband. Fibrob
lasts from different affected individuals all synthesize both normal T
ype I procollagen molecules and abnormal Type I procollagen molecules
in which one or both pro alpha 1 (I) chain(s) contain a cysteine resid
ue within the triple helical domain. Protein studies of the proband lo
calized the mutant cysteine residue to the alpha 1 (I) CB 8 peptide.(1
) We now report that cysteine has replaced glycine at triple helical r
esidue 175 disrupting the invariant Gly-X-Y structural motif required
for perfect triple helix formation. The consequences include post-tran
slational overmodification, decreased thermal stability, and delayed s
ecretion of mutant molecules.(2) The highly variable phenotype in the
present kindred cannot be explained solely on the basis of the cystein
e for glycine substitution but will require further exploration.